Conference - November 13th, 2012 - Sophia Antipolis

14/11/2012 cabinet avocat

The development of a medication
- Target zero risk for the company
- Development of a medication
- Its protection by Patent and SCP
- Target zero risk for the patient
- Quality control
- Counterfeiting detection
- Battle against counterfeiting
- Role of health organisations

- Ariane Delvoie-Servillat, Manager of Cabinet Weinstein PACA
- Karine Pertays, European Representative, specialized in Chemistry, Cabinet Weinstein
- Marie-Christine Ottini-Bertin, Engineer specialized in Chemistry, 25 years' experience in  the pharmaceutical industry (Sanofi, GSK, Galderma)
- Anne Matarazzo, Patent Attorney, 8 years' experience in the IP department of Galderma
- Anne Parmantier, Lawyer, 20 years' experience in the veterinary pharmaceutical industry (VIRBAC)

- EPWN, European Professional Women's Network, Nice, Côte d'Azur

Conference from 6:30 pm to 9:30 pm

Hôtel Mercure, Sophia Antipolis